Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice

被引:318
作者
Duan, WZ
Guo, ZH
Jiang, HY
Ware, M
Li, XJ
Mattson, MP
机构
[1] NIA, Neurosci Lab, Baltimore, MD 21224 USA
[2] NIA, Comparat Med Sect, Baltimore, MD 21224 USA
[3] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA
[4] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA
关键词
apoptosis; diabetes; Huntington's disease; striatum;
D O I
10.1073/pnas.0536856100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
In addition to neurological deficits, Huntington's disease (HD) patients and transgenic mice expressing mutant human huntingtin exhibit reduced levels of brain-derived neurotrophic factor, hyperglycemia, and tissue wasting. We show that the progression of neuropathological (formation of huntingtin inclusions and apoptotic protease activation), behavioral (motor dysfunction), and metabolic (glucose intolerance and tissue wasting) abnormalities in huntingtin mutant mice, an animal model of HD, are retarded when the mice are maintained on a dietary restriction (DR) feeding regimen resulting in an extension of their life span. DR increases levels of brain-derived neurotrophic factor and the protein chaperone heat-shock protein-70 in the striatum and cortex, which are depleted in HD mice fed a normal diet. The suppression of the pathogenic processes by DR in HD mice suggests that mutant huntingtin promotes neuronal degeneration by impairing cellular stress resistance, and that the body wasting in HD is driven by the neurodegenerative process. Our findings suggest a dietary intervention that may suppress the disease process and increase the life span of humans that carry the mutant huntingtin gene.
引用
收藏
页码:2911 / 2916
页数:6
相关论文
共 65 条
  • [51] Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity
    Rios, M
    Fan, GP
    Fekete, C
    Kelly, J
    Bates, B
    Kuehn, R
    Lechan, RM
    Jaenisch, R
    [J]. MOLECULAR ENDOCRINOLOGY, 2001, 15 (10) : 1748 - 1757
  • [52] BODY-WEIGHT AND DIETARY FACTORS IN HUNTINGTONS-DISEASE PATIENTS COMPARED WITH MATCHED CONTROLS
    SANBERG, PR
    FIBIGER, HC
    MARK, RF
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1981, 1 (08) : 407 - 409
  • [53] Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia
    Schäbitz, WR
    Sommer, C
    Zoder, W
    Kiessling, M
    Schwaninger, M
    Schwab, S
    [J]. STROKE, 2000, 31 (09) : 2212 - 2217
  • [54] Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington's disease transgenic mouse model
    Schilling, G
    Coonfield, ML
    Ross, CA
    Borchelt, DR
    [J]. NEUROSCIENCE LETTERS, 2001, 315 (03) : 149 - 153
  • [55] Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin
    Schilling, G
    Becher, MW
    Sharp, AH
    Jinnah, HA
    Duan, K
    Kotzuk, JA
    Slunt, HH
    Ratovitski, T
    Cooper, JK
    Jenkins, NA
    Copeland, NG
    Price, DL
    Ross, CA
    Borchelt, DR
    [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (03) : 397 - 407
  • [56] Schober A, 1998, J NEUROSCI, V18, P7272
  • [57] Wanagat J, 1999, TOXICOL SCI, V52, P35
  • [58] Caloric intake and aging
    Weindruch, R
    Sohal, RS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (14) : 986 - 994
  • [59] Yu BP, 2001, ANN NY ACAD SCI, V928, P39
  • [60] Yu ZF, 1999, J NEUROSCI RES, V57, P830, DOI 10.1002/(SICI)1097-4547(19990915)57:6&lt